
Practical strategies are needed in health centers between cardiologists and oncologists to ensure patients with hereditary transthyretin amyloidosis (ATTRv) receive a comprehensive phenotypic workup and optimal care, according to a study being presented at AHA 2024.
Researchers sought enhance multidisciplinary care from cardiology and neurology teams for patients with ATTRv. Cardiologists and neurologists from three amyloidosis centers analyzed two focus groups, completed surveys, and collected patient chart audits to assess disease management and clinical workflows. In audit-feedback sessions, care teams assessed data and developed action plans to mitigate gaps and enhance patient outcomes.
The results of 30 surveys found that only 13% of institutions had referral protocols for neurologic workup of ATTRv, and over half (51%) of providers were neutral or felt care coordination was ineffective. Similarly, the findings of 151 patient charts showed that only 10% of patients completed PN screening to confirm diagnosis.